Per- and Polyfluoroalkyl Substances (PFAS) in Breast Milk: Concerning Trends for Current-Use PFAS.

Alkanesulfonic Acids / analysis Female Fluorocarbons / analysis Humans Milk, Human / chemistry United States
PFAS regulation breast milk lactation exposure perfluorooctanesulfonic acid (PFOS) perfluorooctanoic acid (PFOA) short-chain PFAS transfer efficiency

Journal

Environmental science & technology
ISSN: 1520-5851
Titre abrégé: Environ Sci Technol
Pays: United States
ID NLM: 0213155

Informations de publication

Date de publication:
01 06 2021
Historique:
pubmed: 14 5 2021
medline: 2 7 2021
entrez: 13 5 2021
Statut: ppublish

Résumé

This is the first study in the last 15 years to analyze per- and polyfluoroalkyl substances (PFAS) in breast milk collected from mothers (

Identifiants

DOI: 10.1021/acs.est.0c06978 PMID: 33982557
pubmed: 33982557
doi: 10.1021/acs.est.0c06978
doi:

Substances chimiques

Alkanesulfonic Acids 0
Fluorocarbons 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

7510-7520

Subventions

Organisme : NIEHS NIH HHS
ID : R01 ES019620
Pays : United States

Auteurs

Guomao Zheng (G)

Paul H. O'Neill School of Public and Environmental Affairs Indiana University, Bloomington, Indiana 47405, United States.
ORCID: 0000-0002-5235-9950

Erika Schreder (E)

Toxic-Free Future, Seattle, Washington 98103, United States.

Jennifer C Dempsey (JC)

Toxic-Free Future, Seattle, Washington 98103, United States.

Nancy Uding (N)

Toxic-Free Future, Seattle, Washington 98103, United States.

Valerie Chu (V)

Toxic-Free Future, Seattle, Washington 98103, United States.

Gabriel Andres (G)

Toxic-Free Future, Seattle, Washington 98103, United States.

Sheela Sathyanarayana (S)

Department of Pediatrics, University of Washington/Seattle Children's Research Institute, Seattle, Washington 91807, United States.

Amina Salamova (A)

Paul H. O'Neill School of Public and Environmental Affairs Indiana University, Bloomington, Indiana 47405, United States.
ORCID: 0000-0003-2174-030X

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Composés chimiques organiques › Composés du soufre › Acides du soufre › Acides sulfoniques › Acides alcanesulfoniques › Per- and Polyfluoroalkyl Substances (PFAS) in...
questionsmedicales.fr › Composés chimiques organiques › Hydrocarbures › Hydrocarbures halogénés › Hydrocarbures fluorés › Fluorocarbones › Per- and Polyfluoroalkyl Substances (PFAS) in...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Per- and Polyfluoroalkyl Substances (PFAS) in...
questionsmedicales.fr › Aliments et boissons › Aliments › Produits laitiers › Lait › Lait humain › Per- and Polyfluoroalkyl Substances (PFAS) in...
questionsmedicales.fr › Régions géographiques › Amériques › Amérique du Nord › États-Unis › Per- and Polyfluoroalkyl Substances (PFAS) in...